Company intelligence / Profile preview

Uro Medical

Boca Raton, Florida, United Statesuromedical.com ↗

Ownership: Private
Development stage: NDA

Overview

Uro Medical is developing the Protect PNS, a wirelessly powered, minimally invasive micro-neurostimulator for treating overactive bladder. The company is running two major randomized controlled clinical trials—GUARDIAN and PROTECT—to evaluate safety and efficacy versus pharmaceutical management. CMS has granted coverage for trial participants. The Protect PNS is currently investigational and under FDA review.

Therapeutic areas: Men's HealthUrology
Modalities: DeviceNeurostimulation deviceNanotechnology-based medical device (microtechnology neurostimulator)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Protect PNS

NDA

Indications: Overactive bladder

Partnerships

Center for Medicare & Medicaid Services (CMS) coverage partnership for GUARDIAN trial

Beyond the preview

Go deeper on Uro Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uro Medical.

Explore the full profile